CONFIDENTIAL GPEx® DEVELOPMENT AND MANUFACTURING AGREEMENTQuality Agreement • July 9th, 2018 • Vaccinex, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 9th, 2018 Company Industry JurisdictionThis GPEx® Development and Manufacturing Agreement (“Agreement”) is made as of January 13, 2010 (“Effective Date”), by and between Vaccinex, Inc., a with a place of business at 1895 Mt. Hope Avenue, Rochester, NY 14620, USA (“Vaccinex”) and Catalent Pharma Solutions, LLC, a Delaware limited liability company, with a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873, USA (“Catalent”).
CONFIDENTIAL GPEx® DEVELOPMENT AND MANUFACTURING AGREEMENTQuality Agreement • April 13th, 2018 • Vaccinex, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2018 Company Industry JurisdictionThis GPEx® Development and Manufacturing Agreement (“Agreement”) is made as of January 13, 2010 (“Effective Date”), by and between Vaccinex, Inc., a with a place of business at 1895 Mt. Hope Avenue, Rochester, NY 14620, USA (“Vaccinex”) and Catalent Pharma Solutions, LLC, a Delaware limited liability company, with a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873, USA (“Catalent”).